Chlamydia trachomatis infection does not enhance local cellular immunity against concurrent Candida vaginal infection

Infect Immun. 2001 May;69(5):3451-4. doi: 10.1128/IAI.69.5.3451-3454.2001.

Abstract

Although Th1-type cell-mediated immunity (CMI) is the predominant host defense mechanism against mucosal Candida albicans infection, CMI against a vaginal C. albicans infection in mice is limited at the vaginal mucosa despite a strong Candida-specific Th1-type response in the draining lymph nodes. In contrast, Th1-type CMI is highly effective against an experimental Chlamydia trachomatis genital tract infection. This study demonstrated through two independent designs that a concurrent Candida and Chlamydia infection could not accelerate or modulate the anti-Candida CMI response. Together, these results suggest that host responses to these genital tract infections are independent and not influenced by the presence of the other.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • CD4 Lymphocyte Count
  • Candidiasis, Vulvovaginal / immunology*
  • Chlamydia Infections / immunology*
  • Chlamydia trachomatis*
  • Female
  • Lymphocyte Activation
  • Mice
  • Mice, Inbred BALB C
  • Th1 Cells / immunology